Karen Prange
CIK 1566083 · EVP&CEO Gl.AH.Med.Den.Sur.Grp · last filed 2026-06-05
Karen Prange is an EVP&CEO Gl.AH.Med.Den.Sur.Grp who has filed 54 SEC Form 4 insider transactions across 8 companies since 2013. The most recent filing, for OM, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.20M
8
54
-$1.24M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OM | Director | 29,334 | $4.49 | $131.7K | $0 | 2 | 2026-06-05 |
| ATRC | Director | 26,373 | $28.79 | $759.3K | -$352.6K | 11 | 2026-05-22 |
| EMBC | Director | 64,581 | $3.10 | $200.2K | $0 | 5 | 2026-02-13 |
| NEVRO CORP (NVRO) Delisted | Director | 0 | $5.84 | $0 | $0 | 6 | 2025-04-03 |
| ViewRay, Inc. (VRAY) Delisted | Director | 46,399 | $0.03 | $1.2K | $91.2K | 5 | 2023-07-21 |
| CANTEL MEDICAL CORP (CMD) Delisted | Director | 0 | $80.37 | $0 | $0 | 2 | 2021-06-02 |
| HSIC | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 62,902 | $81.25 | $5.11M | $0 | 3 | 2018-03-06 |
| BOSTON SCIENTIFIC CORP (BSXw) Delisted | SVP&Pres, Uro & Pelvic Health | 39,395 | — | — | -$976.2K | 20 | 2016-03-08 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | OM | Grant (A) | +10,667 | $0 | EDGAR |
| 2026-05-22 | ATRC | Sell (S) | −3,000 | -$86.0K | EDGAR |
| 2026-05-20 | ATRC | Grant (A) | +6,144 | $0 | EDGAR |
| 2026-02-13 | EMBC | Grant (A) | +22,841 | $0 | EDGAR |
| 2026-01-12 | OM | Grant (A) | +18,667 | $0 | EDGAR |
| 2025-05-21 | ATRC | Grant (A) | +5,401 | $0 | EDGAR |
| 2025-04-03 | NEVRO CORP (NVRO) Delisted | Disp (D) | −33,948 | $0 | EDGAR |
| 2025-03-07 | ATRC | Sell (S) | −6,100 | -$232.5K | EDGAR |
| 2025-02-14 | EMBC | Grant (A) | +13,839 | $0 | EDGAR |
| 2024-05-28 | NEVRO CORP (NVRO) Delisted | Grant (A) | +19,169 | $0 | EDGAR |